DE ANGELIS, CARLA
 Distribuzione geografica
Continente #
NA - Nord America 224
EU - Europa 127
AS - Asia 119
SA - Sud America 17
AF - Africa 1
Totale 488
Nazione #
US - Stati Uniti d'America 216
SG - Singapore 62
RU - Federazione Russa 42
DE - Germania 24
IE - Irlanda 24
CN - Cina 18
BR - Brasile 15
VN - Vietnam 14
HK - Hong Kong 11
FI - Finlandia 9
IT - Italia 7
BD - Bangladesh 6
UA - Ucraina 5
CA - Canada 4
SE - Svezia 4
FR - Francia 3
JP - Giappone 3
MX - Messico 3
CZ - Repubblica Ceca 2
GB - Regno Unito 2
IN - India 2
PL - Polonia 2
CO - Colombia 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
KZ - Kazakistan 1
LT - Lituania 1
NO - Norvegia 1
PK - Pakistan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 488
Città #
Dallas 35
Singapore 33
Chandler 28
Dublin 24
San Jose 22
Munich 16
The Dalles 13
Ashburn 12
Jacksonville 12
Santa Clara 12
Beijing 11
Hong Kong 11
New York 8
Council Bluffs 7
Ho Chi Minh City 7
Moscow 6
Boardman 5
Columbus 4
Turku 4
Brooklyn 3
Hanoi 3
Helsinki 3
Lawrence 3
Mexico City 3
Orem 3
Princeton 3
Rome 3
Tokyo 3
Atlanta 2
Bremen 2
Brno 2
Falkenstein 2
Frankfurt am Main 2
Lappeenranta 2
Los Angeles 2
Montreal 2
Rio de Janeiro 2
Stockholm 2
Warsaw 2
Ann Arbor 1
Argenteuil 1
Blumenau 1
Caen 1
Cairo 1
Campo Grande 1
Charleston 1
Chicago 1
Conceição do Coité 1
Darlington 1
Dearborn 1
Denver 1
Dhaka 1
Duque de Caxias 1
Gramado 1
Haiphong 1
Hangzhou 1
Itapira 1
Jatai 1
João Câmara 1
Kanpur 1
Karachi 1
Lavras 1
Manchester 1
Maniwaki 1
Medellín 1
Oral 1
Oslo 1
Paris 1
Prudentópolis 1
Puerto Cabello 1
Rohtak 1
San Pedro Sula 1
Santa Helena de Minas 1
Seattle 1
Sioux Falls 1
São Bernardo do Campo 1
São Sebastião do Paraíso 1
Taiyuan 1
Tân Thịnh 1
Verona 1
Viareggio 1
Waterbury 1
Wilmington 1
Totale 363
Nome #
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 150
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 122
Sub-background radiation exposure at the LNGS underground laboratory: dosimetric characterization of the external and underground facilities 119
Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A 103
Totale 494
Categoria #
all - tutte 2.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.330


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 2 0 0 1 1 1 0 4
2022/202369 3 7 0 11 4 7 0 5 30 0 2 0
2023/202427 3 1 3 0 0 9 0 0 0 1 1 9
2024/2025114 7 2 5 7 16 5 12 7 25 5 12 11
2025/2026250 13 15 30 31 18 16 29 11 19 36 19 13
2026/20271 1 0 0 0 0 0 0 0 0 0 0 0
Totale 494